scispace - formally typeset
K

Koen Breyne

Researcher at Ghent University

Publications -  34
Citations -  1366

Koen Breyne is an academic researcher from Ghent University. The author has contributed to research in topics: Mastitis & Staphylococcus aureus. The author has an hindex of 12, co-authored 25 publications receiving 693 citations. Previous affiliations of Koen Breyne include University of Chicago & Harvard University.

Papers
More filters
Journal ArticleDOI

RNA delivery by extracellular vesicles in mammalian cells and its applications.

TL;DR: This Review focuses on the current state of knowledge pertaining to packaging, transport and function of RNAs in extracellular vesicles and outlines the progress made thus far towards their clinical applications.
Journal ArticleDOI

The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release

TL;DR: Evidence is provided that Hamamelitannin (2′,5-di-O-galloyl-d-hamamelose; HAM) specifically affects S. aureus biofilm susceptibility through the TraP receptor by affecting cell wall synthesis and extracellular DNA release of S.Aureus.
Journal ArticleDOI

Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer

TL;DR: The current experimental study with an innovative immunocompetent intraductal model for TNBC pinpoints towards a metastasis-supporting M1 to M2 macrophage polarization in the mammary ducts mediated by 4T1-derived signaling as immunotherapeutic target.
Journal ArticleDOI

Hamamelitannin Analogues that Modulate Quorum Sensing as Potentiators of Antibiotics against Staphylococcus aureus.

TL;DR: The synthesis of 58 analogues of hamamelitannin (HAM), a quorum sensing inhibitor and antimicrobial potentiator, resulted in the identification of an analogue that increases the susceptibility of Staphylococcus aureus towards antibiotics in vitro, in Caenorhabditis elegans, and in a mouse mammary gland infection model, without showing cytotoxicity.
Journal ArticleDOI

Efficacy and Safety of a Bovine-Associated Staphylococcus aureus Phage Cocktail in a Murine Model of Mastitis

TL;DR: The in vivo results complement the in vitro data and support the concept of phage therapy as an innovative alternative or supplementation therapy to antibiotics for the treatment of bovine mastitis.